Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
BGA-1901 by Nexbiome Therapeutics for Helicobacter pylori Infections: Likelihood of Approval
BGA-1901 is under clinical development by Nexbiome Therapeutics and currently in Phase III for Helicobacter pylori Infections. According to GlobalData,...